5.43 Patterns of Nodal Response and Lymphocytosis in Patients with Previously Treated CLL Receiving the Selective Phosphatidylinositol 3-Kinase-Delta (PI3Kδ) Inhibitor, CAL-101 (GS-1101) Alone or in Combination with Rituximab (R) or Bendamustine (B)
Jennifer R. Brown, Thomas M. Jahn, Richard R. Furman, John P. Leonard, Stephen E. Spurgeon, John C. Byrd, Don M. Benson, Steven E. Coutre, Nina D. Wagner-Johnston, Ian W. Flinn, Brad S. Kahl, MarshallVolume:
11
Year:
2011
Language:
english
DOI:
10.1016/j.clml.2011.09.197
File:
PDF, 112 KB
english, 2011
File converter
More search results
More benefits 
